Clinical pharmacology of slow channel blocking agents
Author:
- R.G. McAllisterRMR.G. McAllister
- 1 September 1982
- journal article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 25 (2) , 83-102
Abstract
No abstract availableThis publication has 118 references indexed in Scilit:
- Improved Diastolic Function and Systolic Performance in Hypertrophic Cardiomyopathy after NifedipineNew England Journal of Medicine, 1980
- Nachweis von Verapamil1im mütterlichen und fetalen Blut des Menschen2Geburtshilfe und Frauenheilkunde, 1980
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.Circulation, 1978
- Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.Circulation, 1978
- Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human atria.Circulation, 1976
- Role of the slow current in cardiac electrophysiology.Circulation, 1975
- CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRILCanadian Journal of Physiology and Pharmacology, 1965